Further, as the epidermal growth factor receptor (EGFR) is overexpressed on the surface of different types of cancer cells in the TME including lung cancer cells [45], we proposed to engineer HUVEC-EVs via GE11 peptide, which binds specifically to EGFR and has been widely utilized for targeted drug delivery [46]. The gene discussed is EGFR; the disease is lung cancer.